NAUT — Nautilus Biotechnology, Inc.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1808805 ·
Last close
$1.11
Market Cap
$141.25M
52W High
$4.31
52W Low
$0.79
ADV30
995,162
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 10,000 | -5,000 | -15,763,000 | -14,469,000 | 163,576,000 | 13,166,000 | 32,464,000 |
| Mar 2026 | 0 | — | -16,124,000 | -14,697,000 | 177,779,000 | 14,626,000 | 33,364,000 |
| Dec 2025 | 0 | — | -15,424,000 | -13,781,000 | 191,112,000 | 12,388,000 | 34,139,000 |
| Sep 2025 | 0 | — | -15,472,000 | -13,574,000 | 200,915,000 | 23,875,000 | 31,776,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-50,235,000
Investing CF
$27,494,000
Financing CF
$1,450,000
CapEx
$-1,626,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.45
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-361,186,000
Inventory
—
Receivables
—
ST Investments
$70,865,000
EBIT TTM
$-62,783,000
Pretax Income TTM
$-56,521,000
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$190,000
EBITDA
$-61,346,000
Free Cash Flow
$-29,418,376
Enterprise Value
$73,585,328
Total Cash
$84,031,000
Total Debt
$27,816,000
Shares Out
127,255,223
Trailing EPS
$-0.45
Book Value
$1.03
ROE
-36.2%
ROA
-20.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -66,837,000 | -59,001,000 | 191,112,000 | 34,139,000 | 156,973,000 | -50,696,000 |
| Dec 2024 | 0 | -81,476,000 | -70,780,000 | 242,743,000 | 34,013,000 | 208,730,000 | -59,145,000 |
| Dec 2023 | 0 | -76,152,000 | -63,675,000 | 305,565,000 | 40,212,000 | 265,353,000 | -51,711,000 |
| Dec 2022 | 0 | -63,618,000 | -57,924,000 | 350,052,000 | 35,128,000 | 314,924,000 | -45,806,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-63,000,000
OpCashFlow TTM
$0
Assets (Latest)
$191,112,000
Forward EPS
$-0.74
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SPE | SPECIAL OPPORTUNITIES FUND, INC. | $141.18M | $12.81 | — |
| GLQ | Clough Global Equity Fund | $140.54M | $7.50 | — |
| SRGXF | Surge Copper Corp | $142.00M | $0.37 | — |
| GLATF | Global Atomic Corp | $142.08M | $0.29 | — |
| HOFT | HOOKER FURNISHINGS Corp | $140.17M | $13.11 | — |
News headlines (Yahoo Finance, 1h cache)
Nautilus Biotechnology Q2 Earnings Call Highlights
2026-07-28 14:04 · Yahoo
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
2026-07-28 12:00 · Yahoo
Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans
2026-05-05 11:05 · Yahoo
Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...
2026-04-29 07:05 · Yahoo
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
2026-04-28 12:00 · Yahoo
Here is Why Nautilus Biotechnology (NAUT) is One of the Best Life Sciences Penny Stocks to Buy
2026-04-14 05:59 · Yahoo
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
2026-04-09 12:00 · Yahoo
3 Penny Stocks With Market Caps Over $100M To Watch
2026-06-03 12:05 · Yahoo
Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms
2026-09-04 12:00 · Yahoo
Nautilus Biotechnology Inc (NAUT) Q2 2026 Earnings Call Highlights: Strategic Shifts and ...
2026-07-28 21:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.